Clinical Phenotype and Outcomes of Multisystem Inflammatory Syndrome in Children According to SARS‐CoV‐2 Laboratory Status During 2020–2021: A Retrospective Observational Study
Klinisches Phänotyp und Outcomes des Multisystem-Inflammationssyndroms bei Kindern nach SARS-CoV-2-Laborstatus während 2020–2021: retrospektive Beobachtungsstudie
Health Science Reports · 2026-11 · 9 (11)
DOI: 10.1002/hsr2.73483 ↗Auf einen Blick
Bei 121 Kindern mit MIS-C unterschieden sich klinische, laborchemische und bildgebende Merkmale weitgehend nicht nach SARS-CoV-2-Laborstatus. Nur Fieber in den ersten 24 h war mit Labor-Nachweis assoziiert.
Fragestellung
Unterscheiden sich klinische Merkmale und Outcomes von MIS-C bei Kindern mit und ohne Labor-Nachweis von SARS-CoV-2?
Methode
Retrospektive Beobachtungsstudie im Mofid Children's Hospital, Teheran, Iran, von März 2020 bis Juli 2021; Vergleich von Kindern mit MIS-C nach WHO-Kriterien mit und ohne PCR-/IgG-Nachweis von SARS-CoV-2.
Ergebnisse
121 Patient:innen; 44 (36,4 %) mit Labor-Nachweis von SARS-CoV-2. ICU-Aufnahme 21,5 %, Mortalität 2,5 %. In der multivariablen Analyse war Fieber in den ersten 24 h assoziiert (aOR 2,57; 95 %-KI 1,05–6,30).
Schlussfolgerung der Autor:innen
MIS-C zeigte unabhängig vom SARS-CoV-2-Laborstatus breite und weitgehend überlappende klinische, laborchemische und bildgebende Merkmale; die beobachteten Unterschiede waren explorativ und von begrenztem diskriminativem Wert.
Kernaussagen
- 121 Kinder mit MIS-C; 44 mit Labor-Nachweis von SARS-CoV-2
- ICU-Aufnahme 21,5 %, Mortalität 2,5 %
- Nur Fieber in den ersten 24 h war statistisch assoziiert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 05.11.2026. Verfasst von Shahnaz Armin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Infections Research Center, Research Institute for Children's Health Shahid Beheshti University of Medical Sciences Tehran Iran. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background and Aims Multisystem inflammatory syndrome in children (MIS‐C) is a post‐infectious inflammatory condition associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that can affect multiple organ systems. Data comparing clinical features and outcomes between MIS‐C patients with and without laboratory evidence of coronavirus disease 2019 (COVID‐19) remain limited.
Methods
This retrospective observational study was conducted at Mofid Children's Hospital, a pediatric referral center in Tehran, Iran, between March 2020 and July 2021. Children diagnosed with MIS‐C based on World Health Organization (WHO) criteria were included and classified into groups with and without laboratory evidence of SARS‐CoV‐2 infection according to PCR and/or IgG serology results. Demographic data, clinical manifestations, laboratory and imaging findings, treatments, and outcomes were compared between the groups using univariate and multivariable analyses. A p ‐value < 0.05 was considered statistically significant.
Results
A total of 121 patients with MIS‐C were included, of whom 44 (36.4%) had laboratory evidence of SARS‐CoV‐2 infection. The mean age was 4.74 ± 3.99 years, and 61.2% were male. ICU admission occurred in 21.5% and mortality was 2.5%. In univariate analysis, fever during the first 24 h of hospitalization and antiviral use were more frequent in the group with laboratory evidence, whereas conjunctivitis and elevated C‐reactive protein levels were more common among the group without laboratory evidence; however, CRP did not differ significantly between groups when analyzed as a continuous variable. In multivariable analysis, fever during the first 24 h of hospitalization was the only variable associated with laboratory evidence of SARS‐CoV‐2 infection (aOR 2.57; 95% CI 1.05–6.30; p = 0.040).
Conclusion
MIS‐C presents with broad and largely overlapping clinical, laboratory, and imaging features regardless of SARS‐CoV‐2 laboratory status, and the few observed differences were exploratory and of limited discriminative value. These findings highlight the importance of considering MIS‐C even in the absence of laboratory confirmation of SARS‐CoV‐2 infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Infections Research Center, Research Institute for Children's Health Shahid Beheshti University of Medical Sciences Tehran Iran.
- Iranian Research Center for HIV/AIDS Tehran University of Medical Sciences Tehran Iran.
- Department of Pediatrics, School of Medicine Lorestan University of Medical Sciences Khorramabad Iran.
ORCID-Profile: Seyede Mahsan Hoseini-Alfatemi, Roxana Mansour Ghanaiee, Abdollah Karimi, Arian Ashnaei, Amirata Fakhfouri, Azadeh Jafrasteh, Yasna Soleimani
Zitieren
APA
Armin, S., Hoseini-Alfatemi, S. M., Ghanaiee, R. M., Karimi, A., Rahimidanesh, N., Ashnaei, A., Fakhfouri, A., Jafrasteh, A., & Soleimani, Y. (2026). Clinical Phenotype and Outcomes of Multisystem Inflammatory Syndrome in Children According to SARS‐CoV‐2 Laboratory Status During 2020–2021: A Retrospective Observational Study. Health Science Reports, 9(11). https://doi.org/10.1002/hsr2.73483
Vancouver
Armin S, Hoseini-Alfatemi SM, Ghanaiee RM, Karimi A, Rahimidanesh N, Ashnaei A, et al. Clinical Phenotype and Outcomes of Multisystem Inflammatory Syndrome in Children According to SARS‐CoV‐2 Laboratory Status During 2020–2021: A Retrospective Observational Study. Health Science Reports. 2026;9(11). doi:10.1002/hsr2.73483
BibTeX
@article{Armin2026,
author = {Armin, Shahnaz and Hoseini-Alfatemi, Seyede Mahsan and Ghanaiee, Roxana Mansour and Karimi, Abdollah and Rahimidanesh, Negin and Ashnaei, Arian and Fakhfouri, Amirata and Jafrasteh, Azadeh and Soleimani, Yasna},
title = {Clinical Phenotype and Outcomes of Multisystem Inflammatory Syndrome in Children According to SARS‐CoV‐2 Laboratory Status During 2020–2021: A Retrospective Observational Study},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {11},
doi = {10.1002/hsr2.73483}
}
EUVIMED